Loading companies…
Loading companies…
United States · Biotech
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $250M | Adage Capital Partners L.P. — Role not disclosedARCH Venture Partners — Role not disclosedBlue Owl Healthcare Opportunities — Role not disclosedBoxer Capital — Role not disclosedFairmount — Role not disclosedFarallon Capital Management — Role not disclosedFidelity Management & Research Company — Role not disclosedInc. — Role not disclosedInvus — Role not disclosedLogos Capital — Role not disclosedMoore Strategic Ventures — Role not disclosedOrbiMed — Role not disclosedPoint72 — Role not disclosedTCGX — Role not disclosedT. Rowe Price Investment Management — Role not disclosedVenrock Healthcare Capital Partners — Role not disclosedWoodline Partners LP |